Oxcarbazepine
Product Images NDC 63304-653

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63304-653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Oxstructure)

FDA Label Image

250 mL Carton Label (Carton)

FDA Label Image

Figure 1 (Fig1)

FDA Label Image

Figure 2 (Fig2)

FDA Label Image

Figure 3 (Fig3)

FDA Label Image

Figure 4 (Fig4)

FDA Label Image

250 mL Bottle Label (Label)

250 mL Bottle Label (Label)
This is a description of a medication called Oxcarbazepine in the form of an oral suspension. This medication comes in a 300 mg/5mL liquid solution which must be shaken well before use. It is important to use the medication within 7 weeks of opening the bottle. The medication guide is available for each patient. Lot and expiration information is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.